# A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.

> **NCT03218007** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 83 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **BIOLOGICAL:** blood samples

## Key facts

- **NCT ID:** NCT03218007
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-10
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218007, "A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03218007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*